Envoy Medical (COCH) Cash from Investing Activities (2021 - 2025)
Envoy Medical (COCH) posted Cash from Investing Activities of -$172000.0 for Q4 2025, down 17100.0% sequentially from -$1000.0 in Q2 2025, and down 132.21% YoY from $534000.0 in Q4 2024.
Envoy Medical (COCH) Cash from Investing Activities (2021 - 2025) Analysis & Trends
Envoy Medical has reported Cash from Investing Activities for 5 years, with the latest figure at -$172000.0 in Q4 2025.
- Quarterly Cash from Investing Activities fell 132.21% year-over-year to -$172000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$179000.0 (up 81.73% YoY) and the FY2025 annual result came in at -$179000.0, up 81.73% from the prior year.
- Cash from Investing Activities slipped to -$172000.0 in Q4 2025 per COCH's latest filing, from -$1000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $534000.0 in Q4 2024 and troughed at -$420.0 million in Q1 2021.
- A 5-year average of -$30.5 million and a median of -$60500.0 in 2023 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 2642.86% in 2024, down 7081.82% in 2024.
- Over 5 years, Cash from Investing Activities stood at -$5.0 million in 2021, then soared by 99.18% to -$41000.0 in 2022, then jumped by 48.78% to -$21000.0 in 2023, then surged by 2642.86% to $534000.0 in 2024, then tumbled by 132.21% to -$172000.0 in 2025.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$172000.0, -$1000.0, and -$6000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Envoy Medical | 77.52 Mn | 57.84 Mn | -227,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -172,000.00 |
| Dec 31, 2025 | -172,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Dec 31, 2024 | 534,000.00 |
| Dec 31, 2024 | 534,000.00 |
| Sep 30, 2024 | -615,000.00 |
| Sep 30, 2024 | -615,000.00 |
| Jun 30, 2024 | -790,000.00 |
| Jun 30, 2024 | -790,000.00 |
| Mar 31, 2024 | -109,000.00 |
| Mar 31, 2024 | -109,000.00 |
| Dec 31, 2023 | -21,000.00 |
| Dec 31, 2023 | -21,000.00 |
| Sep 30, 2023 | -62,000.00 |
| Sep 30, 2023 | -62,000.00 |
| Jun 30, 2023 | -11,000.00 |
| Jun 30, 2023 | -11,000.00 |